News - Adcetris

Filter

Current filters:

Adcetris

Popular Filters

Takeda unit posts updated survival data with HL drug candidate Adcetris

15-06-2012

USA based Millennium, a wholly owned oncology subsidiary of Takeda Pharmaceutical (TYO: 4502), yesterday…

AdcetrisMillennium PharmaceuticalsOncologyPharmaceuticalResearchTakeda Pharmaceuticals

“Black box” warning for Seattle Genetics’ Adcetris

16-01-2012

US biotech Seattle Genetics (Nasdaq: SGEN) saw its shares fall 5.2% to $17.49 on Friday, after the company…

AdcetrisBiotechnologyNorth AmericaOncologyRegulationSeattle Genetics

Seattle Genetics gets $5 million Takeda milestone on EMA acceptance of Adcetris MAA

28-06-2011

US biotech firm Seattle Genetics (Nasdaq: SGEN) says it will receive a $5 million payment under its Adcetris…

AdcetrisBiotechnologybrentuximabEuropeLicensingOncologyPharmaceuticalRegulationSeattle GeneticsTakeda Pharmaceuticals

Company Spotlight

Fibrotech

Fibrotech

Back to top